Search Within

Larry Norton

Formats
  1. Journal Article (411)
  2. Meeting Abstract (297)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (762)
  2. Breast Medicine Service (762)
  3. Department of Medicine (762)
  4. Solid Tumor Oncology Division (762)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (31)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (125)
  3. Nature Publishing Group (77)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (43)

More Publishers

Results (762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone mineral density in women with and without a history of breast cancer (BC)
    Meeting Abstract

    Van Poznak, C. H.; Elkin, E.; Norton, L.; Hudis, C.
    Breast Cancer Research and Treatment (2003)

    Fulltext@MSK | Save
  • Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) are expressed in human breast tumors
    Meeting Abstract

    Van Poznak, C. H.; Cross, S. S.; Hudis, C.; Norton, L.; Panageas, K. S.; Coleman, R. E.; Holen, I.
    Breast Cancer Research and Treatment (2003)

    Fulltext@MSK | Save
  • Concordance of estrogen and progesterone receptor status, and Her-2/neu protein expression in paired primary breast carcinomas and lymph node metastases
    Meeting Abstract

    Torres-Matundan, E.; Brogi, E.; Tracey, J.; Norton, L.; Hudis, C.; Robson, M.; Tan, L. K.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • Concordance of estrogen and progesterone receptor status, and Her-2/neu protein expression in paired primary breast carcinomas and lymph node metastases
    Meeting Abstract

    Torres-Matundan, E.; Brogi, E.; Tracey, J.; Norton, L.; Hudis, C.; Robson, M.; Tan, L. K.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply
    Journal Article

    Henderson, I. C.; Norton, L.; Berry, D. A.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    Journal Article

    King, M. C.; Marks, J. H.; Mandell, J. B.; The New York Breast Cancer Study Group
    Science (2003)

    Fulltext@MSK | Save
  • Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
    Journal Article

    Henderson, I. C.; Berry, D. A.; Demetri, G. D.; Cirrincione, C. T.; Goldstein, L. J.; Martino, S.; Ingle, J. N.; Cooper, M. R.; Hayes, D. F.; Tkaczuk, K. H.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/Cancer and Leukemia Group B trial 9741
    Journal Article

    Citron, M. L.; Berry, D. A.; Cirrincione, C.; Hudis, C.; Winer, E. P.; Gradishar, W. J.; Davidson, N. E.; Martino, S.; Livingston, R.; Ingle, J. N.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: A study by the Cancer and Leukemia Group B
    Journal Article

    Weiss, R. B.; Woolf, S. H.; Demakos, E.; Holland, J. F.; Berry, D. A.; Falkson, G.; Cirrincione, C. T.; Robbins, A.; Bothun, S.; Henderson, I. C.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140
    Journal Article

    Parnes, H. L.; Cirrincione, C.; Aisner, J.; Berry, D. A.; Allen, S. L.; Abrams, J.; Chuang, E.; Cooper, M. R.; Perry, M. C.; Duggan, D. B.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save